Industry › BioTech

Press Releases

Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials

Apr 09, 2024 22:30 HKT/SGT

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics

Apr 03, 2024 15:24 HKT/SGT

Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA

Apr 01, 2024 08:39 HKT/SGT

Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical

Mar 29, 2024 14:51 HKT/SGT

Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture

Mar 29, 2024 14:19 HKT/SGT

Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024

Mar 29, 2024 13:32 HKT/SGT

中国生物制药（1177.HK）公布2023全年业绩

Mar 29, 2024 12:15 HKT/SGT

中國生物製藥（1177.HK）公布2023全年業績

Mar 29, 2024 12:09 HKT/SGT

Sino Biopharm (1177.HK) Announces 2023 Annual Results

Mar 29, 2024 11:45 HKT/SGT

Avance Clinical은 세계 백신 대회에서 최신 백신 임상시험 뉴스를 공유합니다. 이 중에는 HIV-1 연구도 포함됩니다

Mar 29, 2024 06:42 HKT/SGT

Avance Clinical將在世界疫苗大會上分享最新的疫苗臨床試驗新聞，包括HIV-1研究

Mar 29, 2024 06:33 HKT/SGT

Avance Clinical将在世界疫苗大会上分享最新的疫苗临床试验新闻，包括HIV-1研究

Mar 29, 2024 06:22 HKT/SGT

AIM Vaccine Announces 2023 Annual Results

Mar 28, 2024 16:29 HKT/SGT

Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study

Mar 28, 2024 14:42 HKT/SGT

艾美疫苗宣佈2023年全年業績

Mar 28, 2024 10:53 HKT/SGT

AIM submitted pre-application for human diploid rabies vaccine

Mar 27, 2024 12:20 HKT/SGT

艾美新型工藝人二倍體狂犬病疫苗申報臨床

Mar 27, 2024 09:42 HKT/SGT

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

Mar 26, 2024 19:00 HKT/SGT

DC Healthcare Continues Growth Momentum with Second DC Body Outlet Opening in USJ Taipan

Mar 25, 2024 19:00 HKT/SGT

Eisai Selected as a Nadeshiko Brand 2024 as a Listed Company Excelling in Promotion of Women in the Workplace

Mar 21, 2024 15:10 HKT/SGT